INS and early-onset autosomal dominant Alzheimer disease: Regardless, in the Alzheimer’s disease patient, there appears to be a decrease in both cerebral insulin levels and the expression of the insulin receptor that occurs early in the course of the disease (Agrawal and Gomez-Pinilla, 2012; Moreira, 2013).